Compare · head to head
Aprogen Biologics vs Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma ranks higher overall — 360 rank 79 vs 10.
Sumitomo Dainippon Pharma leads on Value (77 vs 44), Quality (56 vs 29) and Safety (42 vs 34). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Small | Large |
| ISIN | KR7003060001 | JP3495000006 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 10 | 79 |
| Value | 44 | 77 |
| Quality | 29 | 56 |
| Growth | NR | 60 |
| Safety | 34 | 42 |
| Sentiment | 41 | 44 |
| Quality details | ||
| Profitability | 16 | 59 |
| Cash Truth | 43 | 53 |
Aprogen Biologics vs Whanin PharmAprogen Biologics vs Daewoong PharmaceuticalAprogen Biologics vs Ilyang PharmaceuticalAprogen Biologics vs Dong-A SocioAdd a third stock →
Full analyses: Aprogen Biologics · Sumitomo Dainippon Pharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100